These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1750222)

  • 1. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
    Peskar BA; Cawello W; Rogatti W; Rudofsky G
    J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW
    Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
    Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW
    Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
    Sinzinger H; Rogatti W
    Wien Klin Wochenschr; 1991; 103(18):558-65. PubMed ID: 1750223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
    Leonhardt A; Krauss M; Gieler U; Schweer H; Happle R; Seyberth HW
    Br J Dermatol; 1997 Mar; 136(3):337-40. PubMed ID: 9115911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic concepts for clinical use of prostaglandin E1].
    Schrör K
    Vasa Suppl; 1991; 33():335-6. PubMed ID: 1788746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    Leonhardt A; Schweer H; Wolf D; Seyberth HW
    Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
    Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
    Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.